Vikram Sinha
Pharmaceutical Research and Manufacturers of America(US)Chelsea and Westminster Hospital NHS Foundation Trust(GB)Indian Institute of Information Technology Vadodara(IN)Parul University(IN)
Publications by Year
Research Areas
Statistical Methods in Clinical Trials, Diabetes Management and Research, Diabetes Treatment and Management, Pharmaceutical studies and practices, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK(2015)267 cited
- → Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance(2018)207 cited
- → Pharmacokinetics/pharmacodynamics and the stages of drug development: Role of modeling and simulation(2005)175 cited
- → Phase I Dose Escalation and Pharmacokinetic Study of Enzastaurin, an Oral Protein Kinase C Beta Inhibitor, in Patients With Advanced Cancer(2006)173 cited
- → In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective(2009)161 cited
- → A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation(2020)